跳至主要内容
临床试验/IRCT20210712051854N1
IRCT20210712051854N1招募中3 期

Triple blind evaluation of the efficacy of oral calcium Hydroxy-apatite on postoperative pain and bone mineral density in patients after pertrochanteric fracture surgery

Daroo Salamat Pharmed0 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
65 years 至 no limit(—)
性别
All

入选标准

  • All patients over 65 years referred to Trauma Emergency of Shariati Hospital with pertrochanteric fracture who are candidates for surgery

排除标准

  • Patients who are not candidates for surgery due to medical problems with an ASA score of 3 or higher
  • Patients receiving osteoporosis treatments including bisphosphonates, calcium and vitamin D supplements, or hormone therapy prior to surgery

研究者

发起方
Daroo Salamat Pharmed

相似试验